Drug Trial Radar · NCT07944846
A Prospective, Multicenter, Observational Study to Evaluate the Efficacy and Safety of Dexmedetomidine Hydrochloride Nasal Spray for Preoperative Sedation in Children Under General Anesthesia
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Jun 18, 2026
Primary completion
Jun 30, 2027
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- Tongji HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 18, 2026
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- All sexes, from 2 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This prospective multicenter observational study enrolls children aged 2-17 years receiving preoperative anxiolysis and separation support prior to general anesthesia. Subjects receive intranasal dexmedetomidine spray (1-2.5 μg/kg). Key assessments include Ramsay sedation score within 45 min post-drug, intraoperative MSS aspiration risk score, postoperative agitation, mYPAS/GAD-7 anxiety, PedSQoR recovery and behavioral scores, plus ongoing adverse event documentation (respiratory depression, bradycardia, etc.). The primary aim is to assess real-world efficacy and safety of intranasal dexmedetomidine across pediatric age groups and optimize medication strategies for pediatric comfortable anesthesia. Safety follow-up lasts from consent signing until 7 days after Visit 8.
Conditions
- Preoperative Anxiety in Children
Interventions
Dexmedetomidine hydrochloride nasal sprayDrug
1-2.5μg/kg,Preoperative intranasal spray
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants achieving Ramsay Sedation Score ≥3 at least once within 45 minutes after drug administrationTime frame: Within 45 minutes after intranasal dexmedetomidine administration
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Tongji Hospital
Wuhan, Hubei, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.